Jasper Therapeutics

Redwood City, United States

Jasper Therapeutics is a biotechnology company that develops novel antibody therapies for stem cell transplants.

$30.0M raised

Sep 2025

Post-IPO Equity

Biotechnology Health Care Pharmaceutical Therapeutics

Top Investors

Citadel Samsara BioCapital Abingworth Great Point Partners Amgen

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Jasper Therapeutics

How much funding has Jasper Therapeutics raised?

Jasper Therapeutics has raised $30.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in September 2025.

Who are Jasper Therapeutics's investors?

Jasper Therapeutics's investors include Citadel, Samsara BioCapital, Abingworth, Great Point Partners, Amgen.

Where is Jasper Therapeutics headquartered?

Jasper Therapeutics is headquartered in Redwood City, United States.

What does Jasper Therapeutics do?

Jasper Therapeutics is a biotechnology company that develops novel antibody therapies for stem cell transplants.

What stage is Jasper Therapeutics at?

Jasper Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 19, 2025.

MLA

"Jasper Therapeutics — Funding & Investors." VCBacked, September 19, 2025, https://www.vcbacked.co/company/jasper-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2025). Jasper Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/jasper-therapeutics

Wikipedia (cite web)

{{cite web |title=Jasper Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/jasper-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 19, 2025.